Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Maelor's Volplex makes headway in Asian market:

This article was originally published in Clinica

Executive Summary

UK company Maelor is building up its business throughout Asia with its plasma substitute product, Volplex, having extended its existing agreement with Chinese distributor, Helicon Group, to include South Korea. The Wrexham company made its debut in the Asian market in February this year after appointing Helicon as distributor of Volplex in China. According to Maelor, South Korea is the second largest pharmaceutical market in Asia after China, and it generated over $9bn in revenues in 2002.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts